A Frailty-Based Plasma Proteomic Signature Capturing Overall Health and Well-Being in Older Adults
- PMID: 40760763
- PMCID: PMC12419846
- DOI: 10.1111/acel.70144
A Frailty-Based Plasma Proteomic Signature Capturing Overall Health and Well-Being in Older Adults
Abstract
Frailty is an age-related syndrome characterized by an increased vulnerability to adverse health outcomes in the face of stressors. By deriving a blood-based proteomic signature for frailty, the current study aimed to enhance the understanding of frailty biology and created a person-specific predictor for the risk of frailty and other adverse age-related health outcomes. A 25-protein signature (proteomic frailty index [pFI]) predictive of the cumulative frailty index (FI) in the LonGenity cohort was derived using a penalized regression method. The pFI was significantly correlated with the FI at baseline (Pearson r = 0.58) and showed significant associations with age-related chronic conditions, incident mortality, and clinical measures. In an independent cohort of 5195 participants in the Atherosclerosis Risk in Communities study, pFI was successfully validated with measured FI (r = 0.61, p < 0.001) and was associated with physical frailty at baseline (p < 0.001). The pFI was significantly associated with physical, clinical, and cognitive measures, as well as incident mortality (HR [95% CI] = 1.13 [1.12-1.14]) and dementia (HR [95% CI] = 1.07 [1.05-1.09]) after accounting for demographic factors. The pFI was further validated against FI (r = 0.45, p < 0.001) in a second independent study in 654 participants from the Baltimore Longitudinal Study of Aging. In conclusion, we identified and validated a 25-protein signature as an index of frailty that also captures overall well-being, health, and risk for key age-related diseases.
Keywords: SomaScan assay; frailty; proteomic frailty index; proteomics.
© 2025 The Author(s). Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.
Conflict of interest statement
Dr. Coresh has served on the SomaLogic scientific advisory committee during 2022–2023. The remaining authors declare no competing interests.
Figures
References
-
- American Psychiatric Association, D , and American Psychiatric Association, D . 2013. Diagnostic and Statistical Manual of Mental Disorders: DSM‐5. Vol. 5. American Psychiatric Association.
MeSH terms
Grants and funding
- U01HL096899/NH/NIH HHS/United States
- U01 HL096812/HL/NHLBI NIH HHS/United States
- R01 AG046949/AG/NIA NIH HHS/United States
- R01 AG057909/AG/NIA NIH HHS/United States
- 75N92022D00002/HL/NHLBI NIH HHS/United States
- U01 HL096917/HL/NHLBI NIH HHS/United States
- National Institute on Aging, Intramural Research Program
- Glenn Center for the Biology of Human Aging (Paul Glenn Foundation Grant)
- U01 HL096902/HL/NHLBI NIH HHS/United States
- U01HL096917/NH/NIH HHS/United States
- R01 AG061155/AG/NIA NIH HHS/United States
- U01 HL096814/HL/NHLBI NIH HHS/United States
- U01HL096812/NH/NIH HHS/United States
- U01HL096902/NH/NIH HHS/United States
- 75N92022D00001/HL/NHLBI NIH HHS/United States
- P01 AG021654/AG/NIA NIH HHS/United States
- P30AG038072/AG/NIA NIH HHS/United States
- 75N92022D00004/HL/NHLBI NIH HHS/United States
- R01AG061155/AG/NIA NIH HHS/United States
- R01AG046949/AG/NIA NIH HHS/United States
- R01AG044829/AG/NIA NIH HHS/United States
- R01 AG044829/AG/NIA NIH HHS/United States
- R01AG057548/AG/NIA NIH HHS/United States
- R01 AG057548/AG/NIA NIH HHS/United States
- P30 AG038072/AG/NIA NIH HHS/United States
- P01AG021654/AG/NIA NIH HHS/United States
- 75N92022D00003/HL/NHLBI NIH HHS/United States
- R01 DK124399/DK/NIDDK NIH HHS/United States
- 75N92022D00005/HL/NHLBI NIH HHS/United States
- R01AG057909/AG/NIA NIH HHS/United States
- U01 HL096899/HL/NHLBI NIH HHS/United States
- U01HL096814/NH/NIH HHS/United States
LinkOut - more resources
Full Text Sources
